In this edition:
High throughput functional assays for interpretation of neuromuscular disease genes
Understanding genetic variants in neuromuscular disorder
Clinical spectrum and molecular features of asymptomatic DMD mutations
Unpacking gene expression profile to the single nuclei level in muscle samples
Accounting for phenotypic variability in clinical outcomes
Engaging patients from diverse backgrounds in NMD research
In vivo gene therapy for striated muscle laminopathy
Web-based portal supporting the analysis of MRI-diagnosed neuromuscular patients
Dependent cryptic exon-derived neoepitopes as a diagnostic biomarker for IBM
Clinical trial readiness and validation for VCP-MSP
Please login below to download this issue (PDF)